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COMPARATIVE STUDY ON THE EFFECT OF ANTICHOLINERGIC
COMPOUNDS ON SWEATING*
WALTER B. SHELLEY, M.D., Ph.D. AND PETER N. HORVATH, M.D.
The management and investigation of certain common dermatologic problems
demands that measures be available to inhibit completely sweat gland function.
In our present state of knowledge, such inhibition is most readily achieved by
the use of anticholinergic drugs which temporarily prevent acetyicholine from
acting on the sweat gland. Within recent years the number of anticholinergic
compounds has greatly expanded. An attempt has been made to develop deriva-
tives or analogs which would exhibit a selective or specific anticholinergic effect
with respect to a given organ (e.g., the gastrointestinal tract). In this regard,
evaluation of the effectiveness of these new compounds has been confined to
organs other than the sweat gland. The present investigation, therefore, was
undertaken to provide specific assays on the human sweat gland of both old and
new anticholinergic drugs.
EXPERIMENTAL
I. The initial phase of this study was a comparative evaluation of the effect
of oral administration of fifteen parasympatholytic compounds. Each compound
or dosage level thereof was assayed in five healthy adult male subjects by de-
termining its effect on local sweating induced by the intradermal injection of
0.1 ml. of a 1 per cent aqueous solution of policarpine nitrate. Observations were
made immediately before and two hours after ingestion of the anticholinergic
agents. It was felt that any effect noted for less than two hours would be of slender
practical significance. The observations were made in the summer and on subjects
at bed rest in a room at approximately 75°F. All of the drugs were given two
hours after breakfast.
Sweating was graded on a 0 to 4 basis at one, three, and five minutes after
pilocarpine injections. In all instances the flexor surface of the forearms served
as the test site. Following spraying the area with quinizarin powder to produce
a colorimetric change, it was possible to grade rather sharply as follows:
0 = No sweat puncta
1 = Few sweat puncta
2 = Intermediate number of sweat puncta
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3 = Many sweat puncta4 = Diffuse discoloration of entire area
Initial standardization of this test had revealed that no sweating occurred if
(1) the area was pre-treated by the injection of 1.0 ml. of a 1:100,000 solution of
atropine sulfate, (2) if the room temperature dropped to 60°F. or below, or (3)
if the subject disrobed.
The following drugs* and dosages were randomly administered:
mg.
1. Abbott compound AP-124 1.0
2. Artauc (Lederle) 1.0
3. Asymatrine HBr 10.0
4. Atropine methyl nitrate 2.0
5. Atropine sulfate 0.4
6. Atropine sulfate 1.2
7. Atropine sulfate 3.0
8. Benadryl 100.0
9. Homatropine HBr 0.5
10. Homatropine HBr 1.5
11. Homatropine methyl bromide 2.5
12. Lilly compound 874 1.0
13. Pavatrine 125.0
14. Placebo —
15. Pyribenzamine 100.0
16. Scopolamine HBr 0.6
17. Scopolamine HEr 1.2
18. Scopolamine aminoxide HEr 0.5
19. Syntropan 50.0
20. Trasentine 75.0
To conserve space, the results will not be tabulated. Suffice it to state that
two hours after administration none of the above compounds in the dosage used
had any effect on the pilocarpine sweating test.
It was probable, therefore, that the anticholinergic drugs were acting over a
shorter period. To study this time relationship, eight subjects were each given
3.0 mg. of atropine sulfate orally. Pilocarpine tests were then made every fifteen
minutes for two hours (Table 1). The results indicate that generally the anhidrotic
action of the oral cholinergic drug occurs between 30 and 60 minutes. Significant
reduction in the ability to respond to pilocarpine was not seen before thirty min-
utes nor after sixty minutes.
* Grateful acknowledgment is made to each of the following companies for supplying us
with the following: AP-124 (3 beta-diethylaminoethyl-3 phenyl-2 benzofuranone metho-
bromide) by Abbott Research Laboratories, North Chicago, Illinois; Artane 3- (1 -piperidyl) -
1-cyclohexyl-1-pbenyl-1-propanol HCI by Ledcrle Laboratories Division, Pearl River, New
York; Asymatrine hydrobromide and Atropine methyl nitrate (Eumydrin) by Winthrop
Chemical Company, Inc., New York City; Homatropine methyl bromide (Novatrin) by
Campbell Products, Inc., New York City; Compound 874 (1-methyl-4-piperidyl) diphenyl-
acetate hydrochloride by Lilly Research Laboratories, Indianapolis, Indiana; Pavatrine
by Searle, Chicago, Illinois; Scopolamine aminoxide HBr (Genoscopolamine) by Lobica,
Inc., New York City; Syntropan by Roffmann-LaRoche, Nutley, New Jersey, and Trasen-
tine by Ciba Pharmaceutical Products, Summit, New Jersey.
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II. The second part of this study arose from an effort to ascertain what could
be achieved by topical administration of these atropine-like compounds. Derma-
tology has always had a unique advantage in clinical therapeutics in that drugs
may be applied locally to the skin, thereby providing the possibility of a high
dermal concentration with low levels elsewhere in the body. Nowhere is this
opportunity of more obvious value than in the present example. Atropine and
its analogs are powerful drugs, affecting numerous organs in the body ranging
from the heart to the central nervous system. The sweat gland is assuredly oniy
a lesser satellite in their sphere of influence. Moreover, the sweat gland apparently
TABLE 1
Pilocarpine sweat responses at fifteen minute intervals following oral atropine sulfate*
Local Sweating on Forearm Graded at 1, 3 and 5 minutes
Grading Code:
0 = No sweat puncta
1 = A few sweat puncta
2 = Intermediate number of sweat puncta
3 = Many sweat puncta
4 = Diffuse discoloration of entire area
SUBJECTS' SWEAT RESPONSE
SWEATING *1 *2 *3 *4 j *5 *6 *8
GRADEI) AT Minutes
135 135135 135 135 13 51 35 135
mins.
0 1 2 2 2 33 2 2 3 2 2 3 2 3 42 44 244 2 3 3
15 1 2 2 3 4 4 3 4 4 1 1 2 2 3 4 2 4 4 2 4 4 2 3 3
30 3 3 3 1 3 4 2 4 4 1 1 1 1 1 2 1 1 2 2 4 4 1 2 2
45 0 0 1 1 2 2 2 2 2 1 1 1 1 2 2 1 1 3 1 1 1 1 2 2
60 0 1 1 1 3 3 1 1 2 1 2 2 2 2 3 1 2 3 0 1 1 0 1 375 123123123 02390 123133123 124
105 1 4 4
Atropine sulfate, 3.0 mgm.
shows no special sensitivity to cholinergic drugs. It was hoped that the newer
compounds might present sweat gland specificity, but none was found. Tachy-
cardia, cycloplegia, dryness of the throat, abdominal pain, and agitation are
all effects which may appear concomitantly with the desired anhidrosis when
atropine is given systemically. To secure complete abolition of sweat gland
response (both thermal and pilocarpine) in one normal healthy young male
adult, it was necessary to administer 10.0 mg. of atropine sulfate, with the
consequent appearance of signs of widespread parasympathetic paralysis. In
other words, anhidrosis is not a therapeutic result of systemically administered
cholinergic drugs. Rather, it is a sign of overdosage.
Topical administration would thus seem to be ideally suited to the problem at
hand. Actually, topical atropine or belladonna preparations have been used
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sporadically for many years. Here again the newer synthetic anticholinergic
compounds offer the possibility of increasing the effectiveness of this form of
therapy. It is necessary to appriase each one experimentally since a number of
factors enter into the problem of topical administration. Penetration of a given
compound through the intact epidermis depends upon its inherent physico-
chemical properties, the skin permeability, and the vehicle used. The first and
second are rather fixed, but the last factor offers limitless possibilities. To ascer-
tain the inherent effectiveness of a compound divorced from the topical vehicle
used, the following approach was devised. All of the compounds were introduced
into the skin under standard conditions by iontophoresis. Each compound thus
was given roughly an equivalent electrical "push" since iontophoresis acts only
as an electrical accelerant of absorption, actually in no way changing permeability
characteristics (1). The compound which proved to be most effective by ionto-
phoresis might thus be expected to be the most effective in a suitable vehicle.
Such a technic circumvents the need for otherwise tediously assaying each
compound in numerous penetrant vehicles. It annot be used for electrically
uncharged particles; nor does it assess the permeability of the skin to a compound.
Rather, it gives an overall answer as to the relative effectiveness of a compound
to be applied topically. This includes a summation of: rate of absorption through
epidermis, rote of destruction in skin, rate of circulatory removal, and anticholinergic
activity. A marked alteration in any one of these factors would be directly re-
flected in the results obtained.
The specific technic used consisted of iontophoretic introduction of eleven
anticholinergic compounds into the skin of the back of twenty normal healthy
young adults. The iontophoresis apparatus consisted of a five-channel set with
constant electrode weight. The electrodes were stainless steel plates (4 cm.2)
with four sheets of filter paper interposed. lontophoresis was carried out for one
minute with a current density of 0.12 ma./cm.2 The various compounds were
introduced in a random fashion unknown to the observer. All of the drugs were
applied under the positive pole, the negative pole being the indifferent electrode.
The drugs were freshly prepared in a 1 per cent strength in physiological saline
solution. All were soluble except Artane (Lederle), which proved to be somewhat
insoluble. Forty-five minutes after administration of the twelve compounds, the
men entered a thermal cabinet previously described (2) with the consequent
rapid production of generalized sweating. Sweating in all twelve treated areas
was graded (0 to 4) as soon as the adjacent untreated areas were sweating at a
grade 4 rate (diffuse, purple color upon spraying with quinizarin). The results
presented in Table 2 indicate that five of the eleven had a significant effect on
the sweat gland. Scopolamine hydrobromide appeared to be the most effective
of all the compounds. It completely eliminated sweating in every instance. Atro-
pine methyl nitrate and atropine sulfate were next in effectiveness, reducing the
average sweating to below grade 1. The other two effective compounds were
homatropine methyl bromide and scopolamine aminoxide hydrobromide. The
newer synthetic agents were of little or no effect under the conditions studied.
In addition to direct grading of the anhidrosis, measurements were made on
the size of the anhidrotic patch. If inhibition of sweating was incomplete, this
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area precisely corresponded to the 4 cm.2 area of the electrode. However, in the
case of scopolamine and atropine methyl nitrate and sulfate, the anhidrotic
area extended greatly beyond the treated area due to lymphatic spread of the
compounds. Commonly, scopolamine induced anhidrosis in an area two to three
times the size of the treated site. Invariably, the area of anhidrosis seen following
scopolamine hydrobromide exceeded that produced by atropine methyl nitrate.
The measurements are not reported but they serve as additional proof of the
TABLE 2
Comparative effect on sweating of antichotinergic coot ponnds introdnced into skin
by iontophoresis
Grading Coda: Jontophoresis: anode 1 mm., 0.12 ma/cm0 = No sweat puncta 1% aqueous solution
1 = A few sweat puncta
2 = Intermediate number of sweat
puncta3 = Many sweat puncta4 = Diffuse discoloration of entire
area
COMPOUNO
SUBJECTS' SWEAT RESPONSE AT 1 HOUR
— — —
AVERAGE
SWEAT
RESPONSES S S S S S S S S S S S S S S S S12 34 5 67 89 101112 1314 151617181920
U Abbott AP 124
2.Artane
2
4
3 3
44
0 4
44
3 4
44
4
4
1 4
44
4 4
44
4 4
44
3
4
4 3; 4
44k
4 4
44
3.3
4.0
3.AsymatrineHB 1 44 44 44 4 44 44 43 4 34 4 44 3.8
4. Atropine methyl ni-
trate
5.Atropinesulfate
0
0
0 0
00
0 0
00
0 4
03
0
0
ff 0
41
0 0
02
0 0
10
0
0
0 1
01
0
1
0 0
2!1
0.3
0.8
6. Homatropine HBr.... 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3.9
7. Homatropine methyl
bromide 1 02 00 14 3 44 34 44 4 42 4 42 2.3
8.ScopolaminellBr 0 00 00 00 0 00 00 00 0 00 0 00 0.0
9. Scopolamine aminox-
ideHBr
10.Syntropan
11. Trasentine
12.Control
0
3
2
4
13
21
4 4
44
0313
1414
4 4 4 4
4
4
3
44
44
4 4
34
44
4 4
4L4
434444
4 4; 4
34
44
4 4
4
4
4
4
44
44
4 4
44
2.9
3.4
3.9
4.0
slightly greater effectiveness of scopolamine hydrobromide over atropine methyl
nitrate.
A final commentary on the superiority of scopolamine hydrobromide is the
fact that rechecks of sweating in these areas were made from one to ten days
later. In every instance, partial anhidrosis was still present in the scopolamine-
treated areas, even though normal sweating had returned to the other areas.
This prolonged effect did not extend beyond two weeks in any instance. The
anhidrotic effect from scopolamine hydrobromide, therefore, was more intense,
extended over a larger area, and persisted a longer time than that produced by
the analogous preparations.
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III. The final step in these studies consisted of a transfer of the results of ion-
tophoresis experiments to ordinary topical application. On the basis of previous
work on histamine absorption, it could be predicted that use of high concentra-
tions in aqueous solution would provide the most rapid absorption. Accordingly,
studies were made on the effect of simply applying aqueous solutions of scopola-
mine hydrobromide to the skin for a single ten-mihute period. Sweating in these
areas during thermal stimulation was graded as before. It was found that by the
use of a 1 per cent solution, sweating was reduced to grade 1 within several
hours. It remained at this level for five days, returning to normal only after
eight days. Even more striking results were obtained by using an 18 per cent
solution of scopolamine hydrobromide on a 6 cm.2 area of the flexor surface of
the forearm. In this instance, complete anhidrosis appeared in the 16 cm.2 area
within one hour. The anhidrotic area enlarged to cover 70 cm.2 No sweat appeared
in this area during daily tests f or the next eight days. Twenty-three days after
the single application sweating had only returned to a level of grade 1 in an
area covering 40 cm.2 Approximately one month after treatment, sweating re-
turned to normal.
DISCUSSION
Although sweating can be significantly reduced by oral anticholinergic drugs
(3), the data presented indicates the futility of attempting clinically to produce
complete anhidrosis in this manner. The anhidrotic effect can be acheived only
by the use of large doses and then only for short periods of time. This is com-
parable to the findings in studies on the effect of atropine on gastric secretion.
None of the newer synthetic preparations tested proved to be more active than
those which have been in use for many years. An attempt has been made by the
chemists to produce less toxic compounds than atropine. This can be attained
only by the development of compounds with a pharmacologic specificity for
the particular end-organ concerned. If the drug acts over the entire parasympa-
thetic system, it must necessarily remain "toxic" in any therapeutic dosage due
to unwanted side effects. The present studies show that none of the compounds
has a specificity for the sweat gland.
The results obtained in the study on topical administration are more interest-
ing. Here, a comparative study revealed real differences in activity. The anti-
cholinergic drugs are a closely related group of chemical structures, composed
of a tropane and tropic acid radical with certain prosthetic groups which serve
to block the parasympathetic chemical mediator, acetyicholine (4). Reference
may be made to the organic formulae in Goodman and Gilman's text (5) or in
Henry's monograph (6). The biologic effects of these compounds are even bound
to stereoisomerism related to an asymmetric C atom, thus scopolamine is levo-
rotatory (1) hyoscine. D-hyoscine is much less active. Atropine is a racemic
mixture of D- and L-hyoscyamine; actually L is the form more active on the
end-organs.
There is close correlation between the results of this study and those of Nyman
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(7), who studied the comparative effect of anticholinergic compounds as pilo-
carpine antagonists in the eye. Nyman found the following relative activities:
Scopolamine 300
Atropine methyl nitrate 220
Atropine sulfate 100
Homatropine methyl nitrate 25
Homatropine HBr 4
Trasentine 0.15
Syntropan 0.05
The close agreement and the data presented in Table II indicate that apparently
absorption through the epidermis is not a critical factor. Rather, the inherent
activity of the compound is more likely to be the determinant of activity when
administered topically. It was felt that possibly some weak anticholinergic agent
might penetrate the epidermis so rapidly as to produce a greater anhidrosis than
the more active but more slowly absorbed compounds. This has not proven to
be the case.
The demonstration that anhidrosis of long duration may be produced by a
single application to intact skin of a concentrated aqueous solution of hyoscine
is not without potential usefulness in both experimental and clinical studies.
However, a strong note of caution is necessary. These solutions are extremely
dangerous. In some of this work, the hyoscine content of a single milliliter of
solution (180 mg.) was sufficient to cause rapid death if absorbed. Such solutions
cannot be applied to an area of dermatitis in view of the accelerated rate of
absorption—nor can they be applied by the patient. Spreading the solution over
a large area could promote rapid absorption with alarming systemic signs. On
the other hand, the truly striking inhibition of sweating never is to be seen fol-
lowing the application of homeopathic concentrations. If a low concentration is
used, destruction and removal keep fully apace with absorption. Accordingly,
effects on the sweat gland do not appear.
These topical solutions have no effect on the sweat glands of the palms or
soles. Here, absorption of topically applied solids is inappreciable due to the
absence of a major route for absorption, viz., the folliculo-sebaceous appendage.
Moreover, they are without effect on the adrenergic component of sweating (8).
CONCLUSIONS
1. Fifteen anticholinergic drugs given orally to man in clinical dosages proved
to have no effect on pilocarpine-induced local sweating two hours after ad-
ministration.
2. High oral doses of atropine sulfate (3.0 mg.) significantly reduced pilo-
carpine sweating response during the period of from 30 to 60 minutes after ad-
ministration.
3. Following topical administration by iontophoresis, scopolamine HBr, atro-
pine methyl nitrate, and atropine sulfate proved to be the most effective of
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eleven anticholinergie drugs in preventing local sweating in response to thermal
stimulation.
4. A single topical application of concentrated aqueous solutions of scopola-
mine HBr (1-hyoscine HBr) induced local anhidrosis persisting for weeks after
application.
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